Loading...
Reach Banner
Keywords
Last name
Institution

Mary Shago

Concepts (371)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of publications Most Recent Publication Publications by all authors Concept score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
2020
297
2.110
Why?
Chromosome Aberrations
10
2020
168
2.050
Why?
Oncogene Proteins, Fusion
11
2019
74
1.660
Why?
Translocation, Genetic
9
2019
153
1.620
Why?
Gene Rearrangement
7
2018
59
1.550
Why?
Gene Fusion
3
2018
12
1.130
Why?
In Situ Hybridization, Fluorescence
18
2020
253
1.080
Why?
Transcription Factors
4
2016
481
0.980
Why?
Cytogenetic Analysis
5
2020
47
0.970
Why?
DNA-Binding Proteins
3
2016
449
0.850
Why?
Trans-Activators
2
2016
151
0.690
Why?
Sarcoma, Ewing
3
2018
43
0.680
Why?
Chromosomes, Human, X
2
2007
40
0.670
Why?
Sarcoma
5
2018
68
0.670
Why?
Karyotyping
10
2019
140
0.660
Why?
Brain Neoplasms
7
2019
1016
0.600
Why?
Biomarkers, Tumor
7
2018
281
0.570
Why?
Leukemia, Myeloid, Acute
3
2015
178
0.540
Why?
Humans
58
2020
36502
0.540
Why?
Glioma
4
2019
385
0.530
Why?
Leukemia, Myeloid
3
2010
33
0.530
Why?
Chromosomes, Human, Pair 10
2
2011
44
0.520
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2012
439
0.450
Why?
Homeodomain Proteins
4
2018
171
0.450
Why?
Immunohistochemistry
8
2019
573
0.430
Why?
Bone Neoplasms
4
2018
106
0.430
Why?
Transcription, Genetic
4
2007
291
0.400
Why?
Receptors, Retinoic Acid
4
1997
18
0.390
Why?
Chromosome Banding
6
2017
60
0.390
Why?
Chromosome Deletion
4
2013
199
0.390
Why?
Female
35
2019
21965
0.390
Why?
Receptor Protein-Tyrosine Kinases
2
2019
102
0.380
Why?
Leukemia, Megakaryoblastic, Acute
1
2006
15
0.380
Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
2
2017
10
0.380
Why?
Soft Tissue Neoplasms
3
2018
52
0.370
Why?
Kidney Neoplasms
2
2018
123
0.360
Why?
Neuroblastoma
2
2019
262
0.360
Why?
Repressor Proteins
4
2018
170
0.360
Why?
Proto-Oncogene Proteins B-raf
2
2017
63
0.340
Why?
Gene Expression Regulation, Neoplastic
3
2019
402
0.340
Why?
Genetic Predisposition to Disease
4
2018
1043
0.340
Why?
Child
26
2020
16426
0.330
Why?
Diploidy
2
2019
9
0.330
Why?
Bone Marrow
4
2017
99
0.320
Why?
Cell Transformation, Neoplastic
4
2015
151
0.320
Why?
Proto-Oncogenes
1
2004
17
0.320
Why?
Chromosomes, Human, Pair 9
1
2004
29
0.320
Why?
Mutagenesis, Insertional
1
2004
49
0.320
Why?
Adolescent
20
2019
12280
0.310
Why?
Developmental Disabilities
3
2016
344
0.300
Why?
Phenotype
8
2018
1343
0.300
Why?
Smith-Magenis Syndrome
2
2013
7
0.290
Why?
Tretinoin
4
1997
40
0.290
Why?
Ring Chromosomes
1
2002
2
0.290
Why?
Male
23
2019
21222
0.290
Why?
Antineoplastic Agents
1
2007
510
0.280
Why?
Biopsy, Needle
3
2018
81
0.270
Why?
DNA Helicases
2
2012
55
0.260
Why?
Sequence Deletion
2
2015
210
0.260
Why?
Infant
16
2019
9126
0.250
Why?
Abnormalities, Multiple
2
2012
378
0.250
Why?
Prognosis
5
2020
1574
0.240
Why?
Gene Dosage
4
2009
139
0.240
Why?
Gene Amplification
2
2019
77
0.240
Why?
Chromosome Mapping
4
2012
497
0.230
Why?
Granuloma, Giant Cell
1
2019
3
0.230
Why?
Ribonucleoproteins
2
1997
32
0.230
Why?
Mandibular Diseases
1
2019
9
0.230
Why?
Osteosarcoma
2
2018
64
0.230
Why?
Rhabdomyosarcoma, Embryonal
1
2019
19
0.220
Why?
Tumor Suppressor Protein p53
3
2018
272
0.220
Why?
Child, Preschool
14
2019
11075
0.220
Why?
Calcium-Binding Proteins
2
1997
111
0.220
Why?
Genomics
2
2020
240
0.220
Why?
Chromosomes, Human, Pair 15
1
2019
46
0.220
Why?
Chromosomes, Human, Pair 2
1
2019
57
0.210
Why?
Chromosomes, Human, Pair 17
3
2013
43
0.210
Why?
Epigenomics
1
2019
77
0.210
Why?
Medical Oncology
1
2020
107
0.210
Why?
DNA Methylation
2
2019
385
0.210
Why?
Genome, Human
3
2018
332
0.200
Why?
Bone Marrow Diseases
2
2015
70
0.200
Why?
Mosaicism
2
2019
72
0.200
Why?
Down Syndrome
2
2010
86
0.200
Why?
Sella Turcica
1
2017
4
0.190
Why?
Perivascular Epithelioid Cell Neoplasms
1
2017
3
0.190
Why?
Chromosomes, Human
3
2019
41
0.190
Why?
Chromosome Duplication
2
2013
23
0.190
Why?
Base Sequence
7
2007
855
0.190
Why?
Cell Count
1
2017
86
0.190
Why?
Tropomyosin
1
2016
5
0.180
Why?
Mutation
6
2019
1996
0.180
Why?
Carcinoma, Renal Cell
1
2016
27
0.180
Why?
Sequence Analysis, RNA
1
2016
42
0.180
Why?
Chromosomes, Human, Pair 8
2
2007
27
0.180
Why?
CpG Islands
1
1996
122
0.170
Why?
Exoribonucleases
1
2015
5
0.170
Why?
Middle Aged
6
2018
2756
0.170
Why?
DNA Copy Number Variations
2
2016
348
0.170
Why?
Promoter Regions, Genetic
1
1996
243
0.170
Why?
Cells, Cultured
2
2017
988
0.170
Why?
Clonal Evolution
1
2015
11
0.170
Why?
Polymorphism, Single Nucleotide
4
2013
668
0.160
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2015
36
0.160
Why?
Hemoglobinuria, Paroxysmal
1
2015
18
0.160
Why?
Genetic Association Studies
1
2017
291
0.160
Why?
RNA-Binding Proteins
2
2014
107
0.160
Why?
Gene Expression Profiling
2
2016
432
0.160
Why?
Adult
8
2020
6171
0.160
Why?
Hypothalamic Diseases
1
2013
25
0.150
Why?
Neuroectodermal Tumors, Primitive
1
2014
75
0.150
Why?
Mutation, Missense
1
2015
245
0.150
Why?
Peripheral Nervous System Diseases
1
2013
35
0.150
Why?
Genes, myc
2
2004
51
0.150
Why?
Gene Deletion
1
2015
214
0.150
Why?
Genome-Wide Association Study
1
2016
404
0.150
Why?
MicroRNAs
1
2014
96
0.140
Why?
Metabolic Diseases
1
2013
49
0.140
Why?
Uveal Neoplasms
1
2013
6
0.140
Why?
Telomere
2
2015
78
0.140
Why?
Chromosomes, Human, Pair 3
1
2013
31
0.140
Why?
Genes, p53
2
2010
84
0.140
Why?
Melanoma
1
2013
50
0.140
Why?
Neoplasm Proteins
2
2018
156
0.140
Why?
Lymphoma, Non-Hodgkin
1
2012
28
0.140
Why?
Young Adult
6
2019
2449
0.140
Why?
Salivary Gland Neoplasms
1
2012
5
0.140
Why?
Gene Duplication
2
2012
116
0.130
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2009
306
0.130
Why?
Fourth Ventricle
1
2011
7
0.130
Why?
Disease Progression
4
2019
671
0.130
Why?
Cerebral Ventricle Neoplasms
1
2011
18
0.130
Why?
Diagnosis, Differential
4
2019
795
0.130
Why?
Neoplasms, Neuroepithelial
1
2011
26
0.130
Why?
Cockayne Syndrome
1
2011
4
0.130
Why?
Carcinoma
1
2012
79
0.130
Why?
Animals
11
2015
7758
0.130
Why?
DNA Repair Enzymes
1
2011
30
0.120
Why?
Frameshift Mutation
1
2011
53
0.120
Why?
Adenolymphoma
1
2010
1
0.120
Why?
Parotid Neoplasms
1
2010
5
0.120
Why?
Ifosfamide
2
2007
57
0.120
Why?
Etoposide
2
2007
106
0.120
Why?
Chromosomes, Human, Pair 13
1
2010
30
0.120
Why?
Molecular Sequence Data
6
2007
1261
0.120
Why?
Infant, Newborn
6
2019
5516
0.120
Why?
Mice
7
2012
3654
0.110
Why?
Splenic Diseases
1
2009
12
0.110
Why?
Hamartoma
1
2009
12
0.110
Why?
Chromosome Breakage
1
2009
24
0.110
Why?
Disease Models, Animal
2
2012
902
0.110
Why?
Chromosomes, Human, Pair 6
1
2009
55
0.110
Why?
Chromosomes, Human, Pair 22
2
2011
108
0.110
Why?
Kidney
1
2012
477
0.100
Why?
Gene Expression Regulation
3
2002
473
0.100
Why?
Cullin Proteins
1
2007
9
0.100
Why?
Core Binding Factor Alpha 2 Subunit
1
2007
6
0.100
Why?
Leukemia, Promyelocytic, Acute
1
2007
14
0.100
Why?
Chromosomes, Human, Pair 5
1
2007
31
0.100
Why?
Chromosomes, Human, Pair 4
1
2007
48
0.100
Why?
Oncogenes
1
2007
58
0.100
Why?
Tetralogy of Fallot
1
2010
204
0.100
Why?
Myelodysplastic Syndromes
1
2008
62
0.100
Why?
Burkitt Lymphoma
1
2007
37
0.100
Why?
Survival Analysis
3
2019
596
0.100
Why?
Lymphohistiocytosis, Hemophagocytic
1
2007
33
0.100
Why?
Cyclophosphamide
1
2007
137
0.100
Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2006
14
0.090
Why?
Acute Disease
2
2007
420
0.090
Why?
Trisomy
1
2007
35
0.090
Why?
Central Nervous System Neoplasms
1
2008
130
0.090
Why?
Neoplasms, Second Primary
1
2008
79
0.090
Why?
Apoptosis
2
2007
440
0.090
Why?
Proto-Oncogene Proteins c-myc
2
2007
67
0.090
Why?
Chromosomes, Human, Pair 11
1
2007
142
0.090
Why?
Oligonucleotide Array Sequence Analysis
3
2020
280
0.090
Why?
Ependymoma
1
2008
185
0.090
Why?
Disease-Free Survival
2
2020
359
0.090
Why?
Comparative Genomic Hybridization
2
2017
70
0.090
Why?
Reproducibility of Results
3
2019
1294
0.080
Why?
Sequence Analysis, DNA
1
2007
399
0.080
Why?
RNA, Messenger
3
2006
645
0.080
Why?
Subcutaneous Tissue
1
2004
5
0.080
Why?
Neuroectodermal Tumors, Primitive, Peripheral
1
2004
7
0.080
Why?
Age of Onset
2
2018
450
0.080
Why?
Autistic Disorder
1
2008
290
0.080
Why?
Myeloid-Lymphoid Leukemia Protein
1
2004
8
0.080
Why?
Leukemic Infiltration
1
2004
6
0.080
Why?
Meninges
1
2004
8
0.080
Why?
Histone-Lysine N-Methyltransferase
1
2004
27
0.080
Why?
Lymphoma, B-Cell
1
2004
28
0.080
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2004
27
0.080
Why?
Genetic Variation
1
2006
354
0.080
Why?
Cell Line
3
2012
923
0.080
Why?
Gene Expression Regulation, Developmental
2
2016
404
0.070
Why?
Medulloblastoma
1
2010
625
0.070
Why?
DNA
4
2006
469
0.070
Why?
Recurrence
2
2019
552
0.070
Why?
B-Lymphocytes
1
2004
201
0.070
Why?
DNA Mutational Analysis
2
2015
436
0.070
Why?
Cohort Studies
3
2017
1970
0.070
Why?
Sequence Alignment
2
2006
186
0.070
Why?
Carcinoma, Mucoepidermoid
2
2012
5
0.060
Why?
DNA, Complementary
2
2002
167
0.060
Why?
Retrospective Studies
4
2015
5109
0.060
Why?
Neoplasms
1
2010
1101
0.060
Why?
Pregnancy
3
2019
1956
0.060
Why?
Nuclear Proteins
2
2018
356
0.060
Why?
Calreticulin
2
1997
7
0.060
Why?
False Negative Reactions
1
2019
29
0.060
Why?
Placenta Diseases
1
2019
7
0.060
Why?
Proto-Oncogene Proteins c-met
1
2019
35
0.060
Why?
Cell Line, Tumor
2
2014
487
0.060
Why?
Receptor, trkA
1
2019
30
0.060
Why?
Clinical Decision-Making
1
2020
49
0.060
Why?
Lipase
1
2019
18
0.060
Why?
Paired Box Transcription Factors
1
2019
17
0.060
Why?
Amino Acid Sequence
3
1997
959
0.050
Why?
High-Throughput Nucleotide Sequencing
1
2020
127
0.050
Why?
Protein-Tyrosine Kinases
1
2019
138
0.050
Why?
Spectral Karyotyping
2
2009
6
0.050
Why?
Tumor Cells, Cultured
2
1996
299
0.050
Why?
Proto-Oncogene Proteins
1
2019
163
0.050
Why?
Tissue Array Analysis
2
2009
32
0.050
Why?
Patient Selection
1
2020
223
0.050
Why?
Cloning, Molecular
2
1996
267
0.050
Why?
Nephrectomy
1
2018
52
0.050
Why?
Introns
1
2018
95
0.050
Why?
Neoplasm Metastasis
1
2018
128
0.050
Why?
DNA Replication
1
2018
83
0.050
Why?
Cell Differentiation
2
2002
568
0.050
Why?
Evolution, Molecular
1
2018
120
0.050
Why?
Fatal Outcome
2
2011
220
0.050
Why?
Microarray Analysis
2
2008
83
0.050
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2017
35
0.050
Why?
Retinoid X Receptors
1
1997
2
0.050
Why?
Ubiquitin-Protein Ligases
1
2019
164
0.050
Why?
Aged, 80 and over
1
2018
459
0.050
Why?
Intracellular Fluid
1
1997
25
0.050
Why?
Dimerization
1
1997
73
0.050
Why?
Oligodeoxyribonucleotides
1
1996
26
0.050
Why?
Sequence Homology, Nucleic Acid
1
1996
78
0.050
Why?
Genes
1
1996
86
0.050
Why?
Pedigree
2
2009
634
0.050
Why?
Biological Evolution
1
1996
47
0.040
Why?
Practice Guidelines as Topic
1
2020
472
0.040
Why?
Binding Sites
1
1997
315
0.040
Why?
Risk Assessment
1
2020
896
0.040
Why?
Neoplasm Recurrence, Local
1
2018
282
0.040
Why?
Biopsy
1
2017
326
0.040
Why?
Telomere Homeostasis
1
2015
9
0.040
Why?
Follow-Up Studies
2
2015
2621
0.040
Why?
Up-Regulation
1
1996
174
0.040
Why?
Predictive Value of Tests
1
2018
730
0.040
Why?
Proteomics
1
2016
110
0.040
Why?
Cell Cycle Proteins
1
2016
156
0.040
Why?
Protein Binding
1
1997
522
0.040
Why?
Age Factors
1
2020
1458
0.040
Why?
Myelin Sheath
1
2015
76
0.040
Why?
Calcium
1
1997
362
0.040
Why?
Anemia, Aplastic
1
2015
50
0.040
Why?
Patient Outcome Assessment
1
2015
36
0.040
Why?
Adaptor Proteins, Signal Transducing
1
2016
215
0.040
Why?
Survival Rate
2
2008
732
0.040
Why?
Chromatin
1
2015
100
0.040
Why?
Androgen Receptor Antagonists
1
1994
1
0.040
Why?
Zebrafish
1
2015
159
0.040
Why?
Multigene Family
1
2014
80
0.040
Why?
Point Mutation
1
2015
156
0.040
Why?
Risk
1
2015
260
0.040
Why?
Facies
1
2013
80
0.040
Why?
Kaplan-Meier Estimate
1
2015
394
0.040
Why?
Alleles
1
2015
496
0.040
Why?
Treatment Outcome
2
2015
4020
0.040
Why?
DNA End-Joining Repair
1
2012
7
0.040
Why?
In Situ Nick-End Labeling
1
2012
41
0.040
Why?
Urinary Tract
1
2012
14
0.030
Why?
Embryo, Mammalian
2
1991
226
0.030
Why?
DNA Repair
1
2012
78
0.030
Why?
Cystadenocarcinoma
1
2012
1
0.030
Why?
Carcinoma, Acinar Cell
1
2012
1
0.030
Why?
Proto-Oncogene Proteins c-ets
1
2012
7
0.030
Why?
Combined Modality Therapy
1
2013
488
0.030
Why?
Chromosome Disorders
1
2012
60
0.030
Why?
Genetic Testing
1
2015
406
0.030
Why?
Monosomy
1
2011
16
0.030
Why?
Registries
1
2015
428
0.030
Why?
Teratogens
1
1991
15
0.030
Why?
beta-Galactosidase
1
1991
44
0.030
Why?
Heat-Shock Proteins
1
1991
49
0.030
Why?
Trichodermin
1
1990
1
0.030
Why?
Genes, Fungal
1
1990
17
0.030
Why?
Cytoplasmic Structures
1
2010
2
0.030
Why?
Keratins
1
2010
24
0.030
Why?
Plasma Cells
1
2010
8
0.030
Why?
Ribosomal Proteins
1
1990
30
0.030
Why?
Proto-Oncogene Proteins c-kit
1
2010
23
0.030
Why?
Protein Biosynthesis
1
1990
87
0.030
Why?
Genes, ras
1
2010
27
0.030
Why?
Saccharomyces cerevisiae
1
1990
87
0.030
Why?
Receptor, ErbB-2
1
2010
30
0.030
Why?
Lymphocytes
1
2010
143
0.030
Why?
Signal Transduction
1
1997
1267
0.030
Why?
Mice, Inbred NOD
1
2010
157
0.030
Why?
Mice, SCID
1
2010
193
0.030
Why?
Chromosomes, Human, Pair 19
1
2009
46
0.030
Why?
Treatment Failure
1
2010
174
0.030
Why?
Tumor Suppressor Proteins
1
2010
118
0.030
Why?
Syndrome
1
2010
479
0.030
Why?
Flow Cytometry
1
2010
226
0.030
Why?
Chromosomes, Artificial, Bacterial
1
2009
13
0.030
Why?
Incidental Findings
1
2009
40
0.030
Why?
Muscle Hypotonia
1
2009
25
0.030
Why?
Gene Expression
2
2006
402
0.030
Why?
Rats
2
2007
1286
0.030
Why?
Positron-Emission Tomography
1
2009
87
0.030
Why?
Hernia, Umbilical
1
2009
29
0.030
Why?
Pediatrics
1
2017
969
0.030
Why?
Multivariate Analysis
1
2010
431
0.030
Why?
Canada
1
2015
2099
0.030
Why?
Guidelines as Topic
1
2009
107
0.030
Why?
Pilot Projects
1
2010
485
0.030
Why?
Premature Birth
1
2009
95
0.030
Why?
Face
1
2009
116
0.030
Why?
Cell Growth Processes
1
2007
20
0.030
Why?
Genetics, Medical
1
2008
26
0.030
Why?
Chromosomes, Human, Y
1
2007
12
0.020
Why?
Killer Cells, Natural
1
2007
42
0.020
Why?
Aged
1
2012
1455
0.020
Why?
Human Genome Project
1
2007
14
0.020
Why?
Blotting, Northern
2
2002
106
0.020
Why?
Chromosomes, Human, Pair 21
1
2007
17
0.020
Why?
INDEL Mutation
1
2007
29
0.020
Why?
Chromosomes, Human, Pair 12
1
2007
41
0.020
Why?
Nucleic Acid Hybridization
1
2007
74
0.020
Why?
RNA, Small Interfering
1
2007
136
0.020
Why?
Haplotypes
1
2007
205
0.020
Why?
Carrier Proteins
1
1990
405
0.020
Why?
Antigens, CD
1
2007
176
0.020
Why?
Vacuoles
1
2007
75
0.020
Why?
Sensitivity and Specificity
1
2010
942
0.020
Why?
RNA, Neoplasm
1
2006
27
0.020
Why?
Brain
1
2016
1542
0.020
Why?
Neoplastic Stem Cells
1
2007
133
0.020
Why?
Radiotherapy
1
2006
91
0.020
Why?
Polymerase Chain Reaction
1
2006
414
0.020
Why?
Genotype
1
2007
753
0.020
Why?
Myeloid Progenitor Cells
1
2004
5
0.020
Why?
Microscopy, Electron, Transmission
1
2004
68
0.020
Why?
Immunophenotyping
1
2004
44
0.020
Why?
Headache
1
2004
43
0.020
Why?
Tomography, X-Ray Computed
1
2009
982
0.020
Why?
Ontario
1
2010
1740
0.020
Why?
Lung Neoplasms
1
2004
95
0.020
Why?
Hematopoietic Stem Cell Transplantation
1
2008
357
0.020
Why?
Plasminogen Activator Inhibitor 1
1
2002
7
0.020
Why?
Cell Cycle
1
2002
118
0.020
Why?
Phosphoproteins
1
2002
162
0.020
Why?
Fibroblasts
1
2002
285
0.020
Why?
Proteins
1
2002
433
0.010
Why?
Receptors, Androgen
1
1994
11
0.010
Why?
Vero Cells
1
1994
28
0.010
Why?
Integrins
1
1994
40
0.010
Why?
Cell Nucleus
1
1994
110
0.010
Why?
TATA Box
1
1991
2
0.010
Why?
Polyribosomes
1
1990
2
0.010
Why?
RNA, Fungal
1
1990
6
0.010
Why?
Genetic Vectors
1
1991
115
0.010
Why?
Drug Resistance, Microbial
1
1990
35
0.010
Why?
Morphogenesis
1
1991
106
0.010
Why?
Mice, Transgenic
1
1991
469
0.010
Why?
Shago's networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description